Weight management in endometrial cancer patients treated with fertility-sparing

Title : Weight management in endometrial cancer patients treated with fertility-sparing

Abstract:

To discussed the effects of weight management in overweight endometrial cancer or atypical hyperplasia patients undergoing fertility-sparing treatment. Women with endometrial cancer or atypical hyperplasia who were treated with fertility-sparing and had BMI ?25 kg/m² were randomly allocated to our weight management group or self-management group. Body morphology and composition, glycolipid metabolism, and tumor outcomes were assessed in both groups before and at 3 and 6 months after intervention. Weight management can improve the studied parameters and complete remission rates in this population.

Audience Take Away Notes:

• Most women with endometrial cancer suffer from overweight and obesity. Overweight and obesity affect the endometrial affect the fertility-sparing outcomes of patients with endometrial cancer.
• There is a lack of evidence on the effectiveness of weight management in fertility-sparing endometrial cancer patients.
• Weight management can improve the body morphology and composition, glycolipid metabolism of fertility-sparing endometrial cancer patients.
• Weight management can improve the complete remission rate of fertility-sparing endometrial cancer patients.
• Patients with endometrial cancer should be given systematic weight management as an adjuvant therapy.

Biography:

Mrs. Li studied Master Degree of Nursing at the Peking University. She then joined the research group of Prof. Jianliu Wang at the Institute of Peking University People's Hospital. She was Vice Chairman of Gynecology Professional Committee of Chinese Nursing Society. She has published more than 30 research articles in Chinese and SCI (E) journals.